Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA.
Am J Clin Nutr. 2019 Feb 1;109(2):369-379. doi: 10.1093/ajcn/nqy290.
The effect of vitamin D supplementation on muscle function in older adults has been tested in randomized trials with mixed results, which may be due to differences in the study participant characteristics, including baseline vitamin D status. The results of 2 meta-analyses of randomized trials suggested a beneficial effect of vitamin D supplementation on muscle function in older adults with low baseline serum 25-hydroxyvitamin D [25(OH)D].
We aimed to test the effect of 12 mo of vitamin D supplementation on lower-extremity power and function in older community-dwelling adults screened for low serum 25(OH)D.
This was a single-center, double-blind, randomized, placebo-controlled trial that included 100 community-dwelling men and women ≥60 y old who had serum 25(OH)D ≤20 ng/mL at screening and a mean ± SD serum 25(OH)D of 20.2 ± 6.7 ng/mL at baseline. Participants were randomly assigned to 800 IU vitamin D3/d (intervention) or placebo. Those in the intervention group whose serum 25(OH)D was <28 ng/mL after 4 mo were given an additional 800 IU vitamin D3/d, whereas all other participants received placebo as an additional pill.
After 12 mo, the mean ± SD serum 25(OH)D was 32.5 ± 5.1 ng/mL in the intervention group and 19.8 ± 7.3 ng/mL in the control group (treatment × time P < 0.001). The change in leg press power, function, and strength did not differ between the 2 groups over 12 mo (all treatment × time P ≥ 0.60), nor did the change in lean mass (treatment × time P ≥ 0.89).
Increasing serum 25(OH)D to >32 ng/mL (on average) over 12 mo did not affect lower-extremity power, strength, or lean mass in older community-dwelling adults. This trial was registered at clinicaltrials.gov as NCT02293187.
维生素 D 补充剂对老年人肌肉功能的影响已在随机试验中进行了测试,但结果不一,这可能是由于研究参与者特征的差异,包括基线维生素 D 状态。两项随机试验的荟萃分析结果表明,在基线血清 25-羟维生素 D [25(OH)D] 水平较低的老年人中,维生素 D 补充剂对肌肉功能有益。
我们旨在测试 12 个月的维生素 D 补充对筛选出血清 25(OH)D 较低的社区居住的老年成年人下肢力量和功能的影响。
这是一项单中心、双盲、随机、安慰剂对照试验,纳入了 100 名社区居住的年龄≥60 岁的男性和女性,筛选时血清 25(OH)D ≤20ng/ml,基线时平均血清 25(OH)D 为 20.2 ± 6.7ng/ml。参与者被随机分配到 800IU 维生素 D3/d(干预组)或安慰剂。在 4 个月后血清 25(OH)D <28ng/ml 的干预组,给予额外的 800IU 维生素 D3/d,而其他所有参与者则服用安慰剂作为额外的药丸。
12 个月后,干预组的平均血清 25(OH)D 为 32.5 ± 5.1ng/ml,对照组为 19.8 ± 7.3ng/ml(治疗×时间 P <0.001)。12 个月时,两组间腿压力量、功能和力量的变化无差异(两组间治疗×时间 P ≥0.60),瘦体重的变化也无差异(治疗×时间 P ≥0.89)。
在 12 个月内将血清 25(OH)D 提高到>32ng/ml(平均)不会影响社区居住的老年成年人的下肢力量、强度或瘦体重。该试验在 clinicaltrials.gov 上注册为 NCT02293187。